MedPath

Treatment of U.S. Veterans with Mild Traumatic Brain Injury with Hyperbaric Oxygen Therapy

Phase 1
Active, not recruiting
Conditions
Mild Traumatic Brain Injury
Hyperbaric Oxygen Therapy
Depression
Interventions
Device: Hyperbaric Oxygen Therapy Chamber
Registration Number
NCT06665633
Lead Sponsor
Nova Southeastern University
Brief Summary

Mild traumatic brain (mTBI) injury affects 400,000 U.S. Veterans resulting in physical, cognitive and mental health symptoms. The Department of Defense (DoD) reported 26 suicides a day from mTBI despite ongoing care for the Veterans. The purpose of this pilot research study is to evaluate the effect of treating Veterans suffering from mTBI or persistent post-concussion syndrome with hyperbaric oxygen therapy (HBOT).

Detailed Description

In 40 male U.S. Veterans, who have had chronic mTBI for at least six months, the effect of HBOT will be measured in this pilot study with online questionnaires before and after HBOT to measure mental health issues (e.g. depression) and brain function (e.g. memory). The questionnaires will be repeated at 6 and 12 months after HBOT. Brain SPECT (single-photon emission computerized tomography) scans, will measure blood flow to the brain's injured areas before and after HBOT. Quantitative Electroencephalography (QEEG)) will measure brain electrical signals before and after HBOT. An overnight sleep study will measure the quality and stages of sleep pre- and post-HBOT. Blood tests will measure inflammation and cellular mitochondrial function (energy production by the cell) before and after HBOT.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • A male U.S. Veteran, suffer from mild traumatic brain injury characterized by:

    1. a confused or disoriented state which lasts less than 24 hours
    2. loss of consciousness for up to 30 minutes
    3. memory loss lasting less than 24 hours. In good health prior to mild traumatic brain injury.
Exclusion Criteria

An individual is ineligible to participate if does not meet the criteria for mild traumatic brain injury and if any of the following apply:

  1. Female gender due to small pilot study and hormonal changes in women.

  2. Current treated or untreated major depression with psychotic or melancholic features, schizophrenia, bipolar disorder, delusional disorders, dementias of any type, and alcoholism or drug abuse

  3. Current heavy use of alcohol or tobacco use (self-report in last 6 months)

  4. Current organ failure (as determined by self-report)

  5. Current treated or untreated rheumatologic and inflammatory disorders, as determined by medical diagnosis of one or more of the following: osteoarthritis, rheumatoid arthritis, lupus erythematosus, spondyloarthropathies - ankylosing spondylitis and psoriatic arthritis, Sjogren's syndrome, gout, scleroderma, infectious arthritis, and polymyalgia rheumatica

  6. Chronic active infections such as HIV, hepatitis B, and hepatitis C (self-report)

  7. History of organ transplant (self-report)

  8. Current primary sleep disorders such as insomnia, sleep related breathing disorders, etc.

    (self-report)

  9. Any allergic disease (self-report) such as allergic asthma

  10. Use of medications that could affect immune function (e.g., steroids, immunosuppressants) (self-report)

  11. Renal insufficiency

  12. Hepatic insufficiency

  13. Currently have no exclusionary diagnoses that could reasonably explain the symptoms of their fatiguing illness and their severity, using the exclusion criteria best described in case definition paper for Chronic Fatigue Syndrome (CFS), as described in detail in Reeves, et all 2003, which clarifies exclusionary conditions.

  14. History of moderate to severe traumatic brain injury or TBI requiring hospitalization in the past five years.

  15. Unstable PTSD or PTSD requiring hospitalization in the past 5 years (stable PTSD is allowed) - this is to reduce the risk of a claustrophobic triggering of PTSD symptoms.

    (limits generalizability of results to mild/moderate stable PTSD)

  16. Are scheduled for surgery during time of hyperbaric oxygen treatments.

Contraindication for HBOT Therapy: untreated collapsed lung.

Relative contraindications for HBOT Therapy: Includes pulmonary diseases including chronic obstructive lung disease, an air blister in the lung that appears on a chest radiograph but does not result in symptoms, upper respiratory or sinus infections, recent ear or thoracic surgery, uncontrolled fever, and claustrophobia. However, these are relative contraindications, which should not deter clinicians from using HBOT to treat patients with severe neurological injuries or other life or limb threatening conditions. The adverse effects of several medications are thought to be increased by HBOT, including bleomycin and doxorubicin. Other exclusions from participation includes pregnancy and participating in another interventional clinical trial of an investigational therapy within 30 days of consent or scheduled for surgery.

Contraindication for brain SPECT scan: Known allergy to radioactive tracer material.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Treatment of U.S. Veterans with mild traumatic brain injury with hyperbaric oxygen therapyOxygen 100 % Gas for InhalationPilot Study - A total of 40 HBOT treatments at 1.5 atmospheres absolute (ATA) for a dive time of 60 minutes, twice a day Monday through Friday. The treatments were separated by an air break of 4 hours on the same day. Measurements of the effectiveness of HBOT in mTBI done before and after HBOT.
Treatment of U.S. Veterans with mild traumatic brain injury with hyperbaric oxygen therapyHyperbaric Oxygen Therapy ChamberPilot Study - A total of 40 HBOT treatments at 1.5 atmospheres absolute (ATA) for a dive time of 60 minutes, twice a day Monday through Friday. The treatments were separated by an air break of 4 hours on the same day. Measurements of the effectiveness of HBOT in mTBI done before and after HBOT.
Primary Outcome Measures
NameTimeMethod
Brain SPECT Scanpre- HBOT and 4 weeks after HBOT

A brain SPECT scan is a type of imaging test that uses a radioactive substance and a special camera to create 3D pictures of the brain. It shows which areas of the brain are functioning the best or worst and how well the blood flows in the brain. The blood flow to the brain was measured pre- and post-HBOT. An infusion of a radioactive tracer, 30 millicurie (mCi) of Tc99m-Ceretec, was injected into the Veteran's IV site. The veteran was placed under the gamma scintillation camera (Siemens E-cam Dual Head) with a low-energy, high-resolution collimator and SPECT images were recorded using the NeuroGam Software Analysis for the numerical calculation of the mean blood flow value for each of the Brodmann Areas - which are the functional areas in the brain.

Secondary Outcome Measures
NameTimeMethod
Zung Anxiety Inventorypre- HBOT and 1, 6. 12 months after HBOT

Self-report questionnaire used to assess anxiety levels.

Zung Depression Inventory IIpre- HBOT and 1, 6. 12 months after HBOT

Self-report questionnaire used to assess the severity of depression.

Brief Pain Inventorypre- HBOT and 1, 6. 12 months after HBOT

Medical questionnaire used to measure pain

Criteria for Traumatic Brain Injury Severitypre- HBOT and 1, 6. 12 months after HBOT

Questionnaire used to measure the severity of traumatic brain injury.

Davidson Trauma Scalepre- HBOT and 1, 6. 12 months after HBOT

Questionnaire used to measure the symptoms of Post Traumatic Stress Disorder

Functional Capacity Scalepre- HBOT and 1, 6. 12 months after HBOT

Self-report scale from 0 to 10 to measure the severity of fatigue and cognitive ability. Better energy and cognitive function is reflected in a higher number.

Pittsburgh Sleep Quality Indexpre- HBOT and 1, 6. 12 months after HBOT

Questionnaire to evaluate sleep quality.

The Quick Environmental Exposure and Sensitivity Inventory (QEESI)pre- HBOT and 1, 6. 12 months after HBOT

Chemical intolerance self-assessment.

Short-Form 36 Health Surveypre- HBOT and 1, 6. 12 months after HBOT

Self-report questionnaire to measure health.

Quantitative Electroencephalographypre- HBOT and 1 month after HBOT

It measures the electrical activity in the form of brain wave patterns of the brain. It is called brain mapping and measures quantitative metrics related to cognitive brain functions. It quantitatively measures the delta, theta, alpha and beta bands.

Overnight Sleep Studypre- HBOT and 1 month after HBOT

The Cerebra software system is used at home and measures the sleep for one night and includes measuring the percentage of oxygen saturation in the blood as % oxygen using a pulse oximeter, measures heart rate in beats per minute on ECG, breathing rate - measures breathes per minute, limb movement - records leg movement per hour, measures total minutes of time spent snoring, measures the sleep position - in minutes of time spent on back or sides, and measures amount of minutes on EEG brain waves in the different sleep stages including: non-rapid eye movement (NREM) sleep, rapid eye movement (REM) sleep, and stages III/IV sleep. A final report summarizes the sleep study findings.

Measure Blood Markers of Inflammationpre- HBOT and 1 month after HBOT

Measure 18 blood cytokines using Q-Plex Array. Measures levels of Tumor Necrosis Factor-1, Interleukin-1a,Interleukin-1b, Interleukin-2, Interleukin-4, Interleukin-5, Interleukin-6,Interleukin -8, Interferon gamma, Interleukin12p70, Interleukin-13, Interleukin-23, Interleukin-15, Interleukin-17, Interleukin-10, Tumor Necrosis Factor alpha, Tumor Necrosis Factor-Receptor II, Tumor Necrosis Factor beta

PTSD Checklist - Stressor Specific Version (PCL-S)pre- HBOT and 1 month after HBOT

Measure PTSD symptoms and severity

Head Injury Questionnaire Disability Scalepre- HBOT and 1 month after HBOT

Symptom severity of head injury

Mitochondrial Functionpre- HBOT and 1 month after HBOT

Mitochondrial function is measured in the peripheral blood mononuclear cells (PBMCs) using the Seahorse™ Assay. The PBMCs reflect functioning of the brain's neurons and will assess if there is mitochondrial repair after hyperbaric oxygen therapy.

Measure DNA Repairpre- HBOT and 1 month after HBOT

DNA repair measured by measuring Nucleotide Excision Repair in peripheral blood mononuclear cells (PBMCs), which is a reflection of what is occurring in the brain's neurons and will assess if there is DNA repair after hyperbaric oxygen therapy. .

Neurocognitive Indexpre- HBOT and 1, 6. 12 months after HBOT

Questionnaire with quantitative assessment of the overall neurocognitive status.

Composite Memorypre- HBOT and 1, 6. 12 months after HBOT

Questionnaire measures the ability to recognize, remember, and retrieve words and geometric figures.

Verbal Memorypre- HBOT and 1, 6. 12 months after HBOT

Questionnaire measures the ability to recognize, remember, and retrieve words.

Visual Memorypre- HBOT and 1, 6. 12 months after HBOT

Questionnaire measures the recognition memory for abstract figures or shapes.

Finger Tappingpre- HBOT and 1, 6. 12 months after HBOT

Online computer test process that measures motor speed and fine motor control.

Symbol Digit Codingpre- HBOT and 1, 6. 12 months after HBOT

Online computer test process that measures complex information, processing accuracy, complex attention, visual-perceptual speed, and information processing speed.

Stroop Testpre- HBOT and 1, 6. 12 months after HBOT

Online computer test process that measures simple reaction time, complex reaction time, Stroop reaction time, inhibition/disinhibition, and frontal or executive skills.

Shifting Attentionpre- HBOT and 1, 6. 12 months after HBOT

Online computer test process that measures the ability to shift from one instruction set to another quickly and accurately.

Continuous Performancepre- HBOT and 1, 6. 12 months after HBOT

Online computer test process that measures vigilance or sustained attention or attention over time

Perception of Emotionspre- HBOT and 1, 6. 12 months after HBOT

Questionnaire measures how well a subject can perceive and identify specific emotions.

Non-Verbal Reasoningpre- HBOT and 1, 6. 12 months after HBOT

Questionnaire measures how well a subject can perceive and understand the meaning of visual or abstract information and recognizing relationships between visual-abstract concepts.

4-Part Continuous Performancepre- HBOT and 1, 6. 12 months after HBOT

It is a four-part online computer test that measures a subject's working memory and sustained attention.

Trial Locations

Locations (1)

Nova Southeastern University

🇺🇸

Fort Lauderdale, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath